CooperCompanies, US21664P1039

CooperCompanies stock falls after outlook cut and activist pressure

Published on 09/21/2026 at 15:19 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

CooperCompanies stock dropped to a 52-week low near USD 51 after a third-quarter miss and reduced fiscal 2026 guidance reported on September 9, 2026. Analysts have since cut earnings estimates and price targets while activists push for strategic changes at the company.

Reinraum-Produktionsanlage für medizinische Geräte mit Technikern an Kontaktlinsen-Fertigungslinien
CooperCompanies Reinraum-Produktion US21664P1039 zeigt automatisierte Kontaktlinsen-Fertigungslinien mit optischer Qualitätsprüfung im sterilen Reinraumbereich, Illustration mit AI erstellt.

CooperCompanies stock (ISIN US21664P1039) has slumped toward a 52-week low near USD 51 after the company missed third-quarter expectations and lowered its fiscal 2026 outlook, a move highlighted on September 9, 2026 in several analyst and media reports.

Guidance cut and earnings miss weigh on sentiment

According to MarketBeat on September 21, 2026, CooperCompanies reported earnings per share of USD 1.15 for its latest quarter, beating the consensus estimate of USD 1.12 by USD 0.03, but the accompanying outlook revisions dampened investor enthusiasm.

In the same update, CooperCompanies set guidance for the fourth quarter of fiscal 2026 at USD 1.05 to USD 1.09 in EPS and for the full fiscal year 2026 at USD 4.51 to USD 4.55 in EPS, narrowing expectations after its third-quarter performance prompted caution about near-term demand trends.MarketBeat

Per commentary from Yahoo Finance on September 21, 2026, the weaker third-quarter showing and lowered outlook contributed to a single-session drop of about 15 percent in CooperCompanies stock and pushed the shares down roughly 40 percent from their recent high.

Strategic review outcome and buyback frame the story

As Yahoo Finance reported on September 21, 2026, CooperCompanies ended a strategic review of its CooperSurgical unit launched in December 2025 and decided not to sell the business after bids received failed to meet management’s valuation expectations.

The same article notes that the aborted sale came alongside a cut in guidance and the share-price decline to a 52-week low near USD 51, intensifying debate about whether the company’s portfolio mix and capital allocation are aligned with shareholder interests.Yahoo Finance

In parallel, CooperCompanies has been emphasizing cash generation and shareholder returns; according to Yahoo Finance, the company highlighted record free cash flow and a USD 1 billion share repurchase authorization as key financial levers supporting its long-term case even as the stock trades near the bottom of its one-year range.

Analyst reactions and valuation signals

According to MarketBeat on September 21, 2026, KeyCorp cut its fourth-quarter 2026 EPS estimate for CooperCompanies from USD 1.21 to USD 1.06 per share after the guidance update, reflecting a reduction of USD 0.15 per share in near-term expectations.

In the same research round-up, Stifel Nicolaus maintained a buy stance with a price objective of USD 70.00, while Piper Sandler downgraded the stock from overweight to neutral and lowered its target from USD 86.00 to USD 59.00, underscoring a wide dispersion of views on upside potential.MarketBeat

Overall, MarketBeat data on September 21, 2026 show five buy ratings, twelve hold recommendations and two sell ratings on CooperCompanies, translating into an average rating of Hold and a consensus price target of USD 71.47, notably above the latest trading levels.MarketBeat

From a valuation perspective, the same MarketBeat overview notes that CooperCompanies recently opened at USD 55.29 on Nasdaq, implying a market capitalization of USD 10.51 billion and a price-earnings ratio of 18.87 based on current earnings, while commentary from StockStory on September 21, 2026 places the forward price-earnings multiple at 11.8 times at a share price of USD 55.38.

Stock performance and risks for investors

As Simply Wall St noted on September 20, 2026, CooperCompanies shares recently delivered a one-day return of 2.82 percent and a seven-day gain of 2.56 percent, but the 30-day share-price return stood at negative 27.46 percent and the one-year total shareholder return was down 18.89 percent as investors reacted to guidance cuts, buyback developments and emerging activist pressure on the board.

The same analysis estimates a fair value for CooperCompanies shares at USD 67.43 versus a latest close near USD 55.00, indicating an implied upside of approximately 22.6 percent if the company can stabilize its earnings trajectory and address strategic questions raised by activist investors.Simply Wall St

Risk factors highlighted by StockStory on September 21, 2026 include a lack of organic revenue growth over the past two years, an estimated sales growth rate of 2.9 percent for the next twelve months and below-average returns on capital, suggesting that management may need to rely more heavily on acquisitions or portfolio changes to reignite growth.

CooperCompanies stock price and latest trading levels

According to recent Nasdaq-based price data cited by MarketBeat on September 21, 2026, CooperCompanies stock opened at USD 55.29, with the shares trading in the United States on the Nasdaq exchange in US dollars.

CooperCompanies stock - key data

  • Company: The Cooper Companies, Inc.
  • ISIN: US21664P1039
  • Ticker: COO
  • Trading venue: Nasdaq
  • Price (as of September 21, 2026): 55.29 USD
  • Market capitalization: 10.51 billion USD (as of September 21, 2026)
  • Sector / Industry: Health Care / Medical Devices
  • Index membership: S&P 500

More news and analyses on CooperCompanies stock

Disclaimer...

en | US21664P1039 | COOPERCOMPANIES | boerse | 70144766 | bgmi